Back | Next |
home / stock / rgls / rgls message board
Subject | By | Source | When |
---|---|---|---|
$pop$... 50% | kzivann | investorshub | 05/11/2022 3:08:35 PM |
Nice news. | kzivann | investorshub | 05/11/2022 12:34:47 PM |
Bid for new low.. | kzivann | investorshub | 05/04/2022 2:41:14 PM |
Premarket large bid. No sales. Buyout rumor? | kzivann | investorshub | 03/31/2022 11:52:54 AM |
znewcar1: RGLS 35% v8,0M c.305 f146M H.31 Haft.3566 | znewcar1 | investorshangout | 03/02/2022 9:12:39 PM |
And now enrollments are completed for the Alport | jimmy667 | investorshub | 02/27/2022 10:16:20 PM |
Interesting after hours buys on news. | kzivann | investorshub | 01/20/2022 11:53:54 PM |
Good job. Wait a year or two.. They | jimmy667 | investorshub | 01/14/2022 3:28:01 AM |
Put in lowish bid after your post. | kzivann | investorshub | 01/10/2022 7:17:07 PM |
WTF? Selling shareholders had 96 million shares of | jimmy667 | investorshub | 01/10/2022 5:27:22 PM |
Regulus checks all the boxes for patient long | jimmy667 | investorshub | 12/01/2021 4:28:31 AM |
Trying some here. Bottom perhaps. | kzivann | investorshub | 11/23/2021 6:26:46 PM |
Some on that first run but im losin | Planopenny | investorshub | 07/07/2021 3:33:30 PM |
Ooofff, you sell? | Porterhouse10 | investorshub | 07/07/2021 3:26:37 PM |
Look at alec!! Boinggggg | Planopenny | investorshub | 07/06/2021 5:31:36 PM |
Uhhh ohhh, come join the HE/PA team, avg | Porterhouse10 | investorshub | 07/06/2021 5:17:15 PM |
I really got bent over here haha | Planopenny | investorshub | 07/06/2021 4:45:03 PM |
* * $RGLS Video Chart 06-10-2021 * * | ClayTrader | investorshub | 06/10/2021 10:10:22 PM |
$RGLS: Monster call volume on July $2.50calls........ 24k | makinezmoney | investorshub | 06/10/2021 6:43:06 PM |
Dump city happened lol | Planopenny | investorshub | 06/10/2021 5:52:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Regulus Therapeutics Inc. Company Name:
RGLS Stock Symbol:
NASDAQ Market:
Regulus Therapeutics Inc. Website:
Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer PR Newswire SAN DIEGO , May 16, 2024 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of inn...
Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates PR Newswire Initiated the fourth cohort of patients in the Phase 1b multiple-ascending dose (MAD) clinical trial of RGLS8429 for the treatment of autosomal dominant polycystic kidney disea...